Table 4.
T0 | T7 | T14 | T30 | T60 | P intragroup | |
---|---|---|---|---|---|---|
n = 20 | n = 18 | n = 16 | n = 15 | n = 13 | ||
Pain | 6.7 (2.1) | 3.6 (1.6) | 3.4 (2.0) | 3.7 (1.9) | 2.5 (1.7) | <.0005 |
Weakness | 5.8 (3.0) | 4.4 (2.2) | 4.6 (3.0) | 4.5 (2.2) | 4.2 (2.6) | <.0005 |
Nausea | 1.6 (2.2) | 0.3 (0.8) | 1.5 (2.8) | 0.5 (1.6) | 1.6 (3.0) | .011 |
Depression | 3.8 (2.9) | 2.1 (2.2) | 2.2 (2.0) | 2.0 (1.5) | 3.7 (2.2) | <.0005 |
Anxiety | 3.2 (3.6) | 2.8 (2.4) | 2.0 (2.2) | 3.1 (2.6) | 3.0 (2.5) | <.0005 |
Drowsiness | 3.6 (3.1) | 3.1 (2.7) | 3.6 (3.2) | 2.7 (2.8) | 2.9 (2.5) | .001 |
Dyspnea | 1.3 (2.4) | 0.7 (1.4) | 1.1 (1.7) | 0.8 (1.4) | 0.8 (1.2) | .04 |
Insomnia | 4.0 (3.0) | 1.1 (1.6) | 1.2 (1.7) | 1.7 (1.9) | 0.9 (1.4) | <.0005 |
Poor appetite | 3.6 (3.0) | 1.6 (1.9) | 2.2 (3.3) | 0.7 (1.9) | 2.2 (3.6) | <.0005 |
Poor well-being | 4.7 (3.5) | 2.1 (2.4) | 2.8 (2.9) | 2.7 (1.4) | 2.5 (2.9) | .001 |
Total ESAS | 38.4 (19.6) | 21.7 (10.8) | 25.2 (17.9) | 22.5 (11.5) | 25.2 (19.6) | <.0005 |
Methadone dose | 9 | 10 (3.2) | 11.2 (7.9) | 11.7 (8.3) | 10.5 (4.7) | .281 |